CytoDyn Inc. Reports Change in Certifying Accountant
Ticker: CYDY · Form: 8-K · Filed: May 16, 2025 · CIK: 1175680
| Field | Detail |
|---|---|
| Company | Cytodyn Inc. (CYDY) |
| Form Type | 8-K |
| Filed Date | May 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, 8-k
TL;DR
CYDY changed its auditor, filing an 8-K on 5/16/25.
AI Summary
CytoDyn Inc. filed an 8-K on May 16, 2025, reporting a change in its certifying accountant. The company, incorporated in Delaware with its principal executive offices in Vancouver, Washington, has updated its filing information as of May 14, 2025. This filing pertains to Item Information regarding changes in the registrant's certifying accountant and financial statements and exhibits.
Why It Matters
A change in a company's auditor can signal potential issues with financial reporting or a disagreement between the company and its previous auditor, which investors should monitor.
Risk Assessment
Risk Level: medium — Changes in certifying accountants can sometimes indicate underlying financial reporting concerns or disagreements, warranting closer investor scrutiny.
Key Players & Entities
- CytoDyn Inc. (company) — Registrant
- May 14, 2025 (date) — Earliest event reported
- May 16, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Vancouver, Washington (location) — Principal executive offices
FAQ
What is the primary reason for CytoDyn Inc. filing this 8-K?
CytoDyn Inc. is filing this 8-K to report a change in its certifying accountant, as indicated by the 'ITEM INFORMATION: Changes in Registrant's Certifying Accountant' section.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 14, 2025.
What is CytoDyn Inc.'s principal executive office address?
CytoDyn Inc.'s principal executive office is located at 1111 Main Street, Suite 660, Vancouver, Washington 98660.
What is the SIC code for CytoDyn Inc.?
The Standard Industrial Classification (SIC) code for CytoDyn Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What other information is included in the Item Information section of this 8-K?
In addition to changes in the certifying accountant, the Item Information section also includes 'Financial Statements and Exhibits'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 16, 2025 regarding CytoDyn Inc. (CYDY).